Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Explore Our Diverse Range Of Offerings
From detailed reports to experts services offered in 15+
Industry Domains
Add 2 More Reports For 20% off
Report Overview
The Japan in vitro diagnostics market was valued at USD 4.22 Billion in 2025, driven by rising elderly population leading to greater diagnostic testing needs, and increasing demand for personalized medicine across the region. The market is anticipated to grow at a CAGR of 6.20% during the forecast period of 2026-2035, with the values likely to reach USD 7.70 Billion by 2035. The market benefits from advanced healthcare infrastructure and growing adoption of molecular diagnostics. Trends such as AI-integrated testing and home-based diagnostics are expected to accelerate growth during the forecast period.
Q1 2026 Market Updates
The US-Israel-Iran conflict, which escalated with joint airstrikes on 28 February 2026, is creating supply and cost pressures on the Japan in vitro diagnostics market. Japan relies on the Middle East for about 90% of its crude oil imports, with 93% transiting the Strait of Hormuz. The resulting energy crisis is raising costs for laboratory operations, cold chain logistics, and diagnostic instrument manufacturing.
Qatar's damaged Ras Laffan facility threatens the global supply of semiconductor-grade helium, critical for both chip fabrication and MRI cooling systems used alongside IVD testing. Japan began releasing 80 million barrels from strategic petroleum reserves on 16 March, but sustained energy prices continue to affect healthcare infrastructure costs. Inflation is forecast to peak at 2.5% year on year.
Japan's IVD market includes both domestic manufacturers like Sysmex and Fujifilm and imported systems from Roche, Abbott, and Siemens Healthineers. The Gulf pharmaceutical transit hub at 90% below pre-war shipping is disrupting reagent supply routes. Air cargo cost increases of 45% from Asia to Europe are raising distribution expenses for components and reagents sourced from European suppliers.
Diagnostic input prices have risen 20% to 30% since the conflict began, with petrol-derived key starting materials for reagent synthesis costing more. The 90% anxiety rate among Japanese citizens about the conflict's economic impact, as measured by Asahi Shimbun, reflects broader cost-of-living concerns that may affect healthcare spending.
Key Takeaways
Government: Japan released 80 million barrels from strategic reserves, but healthcare infrastructure costs continue rising from energy price pressures. With 93% of oil transiting the closed Strait, government health insurance programs face budget adjustments from rising diagnostic costs. Helium supply risks from Qatar threaten MRI operations across Japan's hospital network.
Market: Diagnostic input prices up 20% to 30% are affecting both domestic manufacturers like Sysmex and imported systems from Roche and Abbott. Japanese consumer inflation at 2.5% is putting pressure on healthcare spending and diagnostic service pricing. Helium supply disruption threatens MRI operations and diagnostic imaging capabilities across Japan.
Procurement: Gulf pharmaceutical transit at 90% below pre-war levels is disrupting reagent supply from European manufacturers. Helium procurement for MRI and diagnostic equipment cooling is under acute pressure. Procurement teams are building safety stocks and qualifying alternative reagent suppliers to maintain Japan's diagnostic testing capacity.
2025
Base Year
2019-2025
Historical Period
2026-2035
Forecast Period
-
In June 2023, Sysmex Corporation, Japan, launched a rapid AST system in Europe using proprietary microfluidics, showcasing Japan’s innovation in in vitro diagnostics and strengthening its position in combating antimicrobial resistance globally.
-
A key trend in Japan in vitro diagnostics market is a surge in strategic partnerships. For instance, in December 2024, Precision Biosensor partnered with NIPRO Corporation to introduce Atlyze, enhancing point-of-care diagnostics access nationwide.
-
The market is propelled by a growing elderly population, rising prevalence of chronic diseases, and technological advancements. Leading industry players are offering innovative molecular, immunoassay, and point-of-care diagnostic solutions.
Compound Annual Growth Rate
6.2%
Value in USD Billion
2026-2035
*this image is indicative*
Japan In Vitro Diagnostics Market Overview
In vitro diagnostics (IVD) are laboratory-based tests performed on biological samples such as blood, urine, or tissue to detect diseases, monitor health conditions, and guide treatment decisions. These diagnostics are vital in ensuring accurate, early diagnosis and personalized patient care. The in vitro diagnostics market in Japan is experiencing steady growth due to its aging population, rising chronic disease burden, and advancements in diagnostic technologies. Increased demand for point-of-care testing and government support further contribute to market expansion. The market is poised to grow at a CAGR of 6.20% during the forecast period of 2026–2035.
Japan In Vitro Diagnostics Market Growth Drivers
Innovative Diagnostic Launch to Augment Growth in In Vitro Diagnostics Market in Japan
A key growth driver in the market is the increasing emphasis on advanced diagnostic tools to combat antimicrobial resistance. In July 2024, Shionogi & Co., Ltd. announced the domestic launch of the “Shionogi MIC Dry Plate Cefiderocol,” designed to assess bacterial susceptibility to Fetroja, a treatment for Gram-negative infections. This innovation supports more targeted antibiotic use and strengthens the nation’s infectious disease diagnostics framework. Such advancements are expected to significantly propel market growth in the coming years.
Japan In Vitro Diagnostics Market Trends
The market is experiencing multiple trends, including an increase in regulatory approvals for novel cancer diagnostics, as well as a surge in innovation and strategic collaborations.
Japan In Vitro Diagnostics Market Segmentation
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Product & Services
- Reagents and Kits
- Instruments
- Software and Services
Market Breakup by Technology
- Immunodiagnostics
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Enzyme-Linked Immunospot (ELISPOT)
- Rapid Tests
- Radioimmunoassay (RIA)
- Western Blotting
- Others
- Clinical Chemistry
- Basic Metabolic Panels
- Liver Panels
- Renal Profiles
- Lipid Profiles
- Thyroid Function Panels
- Electrolyte Panels
- Specialty Chemical Tests
- Molecular Diagnostics
- Polymerize Chain Reaction (PCR)
- Isothermal Nucleic Acid Amplification Technology (INAAT)
- Hybridization
- DNA Diagnostics
- Microarray
- Others
- Hematology
- Microbiology
- Coagulation and Haemostasias
- Urinalysis
- Others
Market Breakup by Application
- Infectious Diseases
- Diabetes
- Oncology
- Cardiology
- Drug Testing/Pharmacogenomics
- HIV/AIDS
- Autoimmune Diseases
- Nephrology
- Others
Market Breakup by End User
- Hospitals
- Diagnostic Centers
- Point-of-Care Testing
- Academic Institutes
- Others
Japan In Vitro Diagnostics Market Share
Segmentation Based on Application to Witness Substantial Growth
Among various application areas driving the market, infectious diseases emerge as the dominant segment due to their profound public health impact and escalating demand for accurate diagnostic solutions. According to the Tuberculosis in Japan Annual Report 2022, in 2021, a total of 11,519 new tuberculosis (TB) cases were reported, corresponding to a notification rate of 9.2 per 100,000 population. Among these cases, 73.0% were pulmonary TB (PTB), while extrapulmonary TB (EPTB) accounted for 27.0%. This significant disease burden fuels market growth, supported by government initiatives and rising public awareness, positioning infectious diseases as a key revenue driver in the forecast period.
Purchase the Regional Overview for USD 1099
If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.
Purchase the Regional Overview for USD 1099
If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.
Leading Players in the Japan In Vitro Diagnostics Market
The key features of the market report comprise funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd., established in 1896 and is a global leader in diagnostic solutions. The company develops and manufactures in vitro diagnostic tests and instruments for diseases such as cancer, diabetes, and infectious conditions. Roche’s advanced diagnostic systems and test strips are widely used in Japan, supporting effective disease detection and treatment within clinical and laboratory settings.
Bio-Rad Laboratories, Inc.
Bio-Rad Laboratories is a prominent player in the in vitro diagnostics market. The company offers the QXDx product family, featuring advanced Droplet Digital PCR (ddPCR) systems and assay kits. These tools provide ultrasensitive and precise quantification for diagnostic applications, including chronic myeloid leukemia monitoring, and are gaining regulatory approvals for clinical use.
bioMerieux SA
Established in 1963, bioMérieux SA develops innovative IVD solutions, including molecular biology, immunoassays, and microbiology products. bioMérieux actively supports compliance with the new In Vitro Diagnostic Regulations (IVDR), enhancing patient safety and product quality in the Japan IVD market.
Abbott
Abbott, headquartered in Abbott Park, Illinois, is a key player in the in vitro diagnostics market. The company introduced the ARCHITECT i1000SR, a high-productivity immunoassay analyzer designed to deliver rapid, accurate results. This advanced system supports improved laboratory workflow and enhances diagnostic efficiency, reinforcing Abbott’s strong market presence.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market include Sysmex Corporation, Thermo Fisher Scientific Inc., QIAGEN, Quidel Corporation, and Danaher Corporation.
Key Questions Answered in the Japan In Vitro Diagnostics Market Report
- What was the Japan in vitro diagnostics market value in 2025?
- What is the Japan in vitro diagnostics market forecast outlook for 2026-2035?
- What major factors aid the Japan in vitro diagnostics market demand?
- How has the market performed so far, and how is it anticipated to perform in the coming years?
- What are the market's major drivers, opportunities, and restraints?
- What are the major trends in the Japan in vitro diagnostics market?
- Which product & services is expected to dominate the market segment?
- Which technology is projected to lead the market segment?
- Which application is anticipated to drive the market segment?
- Which end user is likely to dominate the market segment?
- Who are the key players involved in the Japan in vitro diagnostics market?
- What are the current unmet needs and challenges in the market?
- How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?
Pricing Plans
Upto 15% Off
USD
-
$1999 $1799
-
$3099 $2789
-
$4599 $3909
-
$5999 $5099
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Looking for specific insights?
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Report Summary
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product & Services |
|
| Breakup by Technology |
|
| Breakup by Application |
|
| Breakup by End User |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 1,999
USD 1,799
tax inclusive*
- Selected Segments
- Printing Restrictions
- Excel Spreadsheet Delivered via Email
- Full Report
- Periodic Updates
- Post Sales Analysts Support
- Unlimited Prints
Single User License
One User
USD 3,099
USD 2,789
tax inclusive*
- All Segments
- Printing Restrictions
- PDF Delivered via Email
- Custom Report Layout
- Post Sales Analysts Support
- Periodic Updates
- Unlimited Prints
Five User License
Five User
USD 4,599
USD 3,909
tax inclusive*
- All Segments
- Five Prints Available
- PDF Delivered via Email
- Limited Free Customization
- Post Sales Analyst Support
- Custom Report Layout
- Periodic Updates
- Unlimited Prints
Corporate License
Unlimited Users
USD 5,999
USD 5,099
tax inclusive*
- All Segments
- Unlimited Prints Available
- PDF & Excel Delivery via Email
- Limited Free Customization
- Post Sales Analysts Support
- Discount On Next Update
- Custom Report Layout
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Bundle Type
Flash Bundle
20% OFF
Number of Reports: 3
Small Business Bundle
25% OFF
Number of Reports: 5
Growth Bundle
30% OFF
Number of Reports: 8
Enterprise Bundle
35% OFF
Number of Reports: 10
Overview
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 80 Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 100 Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
- 3 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- Complimentary Excel Data Set
- PPT Version of the Report
- Power BI Dashboards
- License Upgrade
- Free Analyst Hours
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
- 5 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- Complimentary Excel Data Set
- PPT Version of the Report
- Power BI Dashboards
- License Upgrade
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
- 8 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- License Upgrade
- Free Analyst Hours - 80 Hours
- Power BI Dashboards
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
- 10 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- License Upgrade
- Power BI Dashboards
- Free Analyst Hours - 100 Hours
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share